1791 / 1851
Good Respose
Poor Respose
Group A
11
Group B
19
Group C
52
Group D
51
Analysed
FOLFIRINOX
alone no CRT
11
FOLFIRINOX + standard
CRT
19
52
FOLFIRINO
X +
high
dose RT
51
Ro Resection 100%
100%
83%
88%
CRM <1mm 0%
0%
14%
7%
No residual
tumour
1/10 (10%)
11/19 (58%) 7/52 (13.5%) 9/46 (20%)